You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 126 No. 6, June 2008 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Socioeconomics and Health Services
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (9)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Aging/ Geriatrics
 •Glaucoma
 •Ophthalmological Disorders, Other
 •Prognosis/ Outcomes
 •Articles for Residents
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Impact of Vision Loss on Costs and Outcomes in Medicare Beneficiaries With Glaucoma

Thomas Bramley, PhD; Patti Peeples, PhD; John G. Walt, MBA; Marta Juhasz, MSPH; Jan E. Hansen, PhD

Arch Ophthalmol. 2008;126(6):849-856.

Objective  To assess the impact of vision loss severity on costs and health outcomes among Medicare beneficiaries with glaucoma.

Methods  A retrospective cohort analysis was conducted using Medicare claims. Patients were stratified into 4 categories: no vision loss, moderate vision loss, severe vision loss, and blindness. Outcomes of interest were mean annual medical costs by category, component costs, and frequency of depression, falls and/or accidents, injury, femur fracture, and nursing home placement.

Results  Multivariate regression analysis showed that patients with any degree of vision loss had 46.7% higher total costs compared with patients without vision loss. Mean total and component costs increased with onset and severity ($8157 for no vision loss to $18 670 for blindness). Patients with vision loss were significantly more likely to be placed in a nursing home (odds ratio = 2.18; 95% confidence interval, 2.06-2.31), develop depression (odds ratio = 1.63; 95% confidence interval, 1.54-1.73), fracture a femur (odds ratio = 1.67; 95% confidence interval, 1.53-2.83), or experience a fall or accident (odds ratio = 1.59; 95% confidence interval, 1.50-1.68) vs patients without vision loss.

Conclusions  Vision loss in glaucoma is costly, and costs increase with severity. There is significantly increased risk of nursing home admission, depression, falls and/or accidents, injury, or femur fracture with vision loss compared with no vision loss.


Author Affiliations: Xcenda, Salt Lake City, Utah (Dr Bramley); Xcenda, Palm Harbor, Florida (Drs Peeples and Juhasz); and Allergan, Inc, Irvine, California (Mr Walt and Dr Hansen).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Substantial adverse association of visual and vascular comorbidities on visual disability in multiple sclerosis
Marrie et al.
Mult Scler 2011;17:1464-1471.
ABSTRACT | FULL TEXT  

Spectral quality of light modulates emotional brain responses in humans
Vandewalle et al.
Proc. Natl. Acad. Sci. USA 2010;107:19549-19554.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.